281 related articles for article (PubMed ID: 22521633)
1. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
[TBL] [Abstract][Full Text] [Related]
2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
3. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
4. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
[TBL] [Abstract][Full Text] [Related]
5. Sensitive derivatization methods for the determination of genotoxic impurities in drug substances using hyphenated techniques.
Raman NV; Prasad AV; Reddy KR
J Pharm Biomed Anal; 2014 Feb; 89():276-81. PubMed ID: 24316427
[TBL] [Abstract][Full Text] [Related]
6. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
Ermer J; Vogel M
Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
[TBL] [Abstract][Full Text] [Related]
7. Identification of pharmaceutical impurities in formulated dosage forms.
Pan C; Liu F; Motto M
J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
[TBL] [Abstract][Full Text] [Related]
8. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
Prajapati KJ; Kothari CS
Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
[TBL] [Abstract][Full Text] [Related]
9. Hyphenated techniques and their applications in natural products analysis.
Sarker SD; Nahar L
Methods Mol Biol; 2012; 864():301-40. PubMed ID: 22367902
[TBL] [Abstract][Full Text] [Related]
10. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of process-related impurities and degradation products in larotaxel.
Che X; Shen L; Xu H; Liu K
J Pharm Biomed Anal; 2011 Jul; 55(5):1190-6. PubMed ID: 21530132
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
[TBL] [Abstract][Full Text] [Related]
13. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
Ramachandra B
Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
[TBL] [Abstract][Full Text] [Related]
14. Eliminating pharmaceutical impurities: Recent advances in detection techniques.
Liu DQ; Sun M; Wu L
Curr Opin Drug Discov Devel; 2010; 13(6):748-57. PubMed ID: 21061235
[TBL] [Abstract][Full Text] [Related]
15. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
16. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
Wu Y
Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
[TBL] [Abstract][Full Text] [Related]
17. Use of hyphenated LC-MS/MS technique for characterization of impurity profile of quetiapine during drug development.
Stolarczyk EU; Kutner A
Acta Pol Pharm; 2010; 67(6):599-608. PubMed ID: 21229874
[TBL] [Abstract][Full Text] [Related]
18. LC-MS characterization of trace impurities contained in calcium folinate.
Francese G; Corana F; Meneghetti O; Marazza F
J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.
Maggio RM; Calvo NL; Vignaduzzo SE; Kaufman TS
J Pharm Biomed Anal; 2014 Dec; 101():102-22. PubMed ID: 24853620
[TBL] [Abstract][Full Text] [Related]
20. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]